论文部分内容阅读
目的本文主要针对依达拉奉治疗急性脑梗死的临床效果进行观察。方法主要针对2010年到2012年到本院进行治疗的84例急性脑梗死患者进行分组治疗,将其中的随机抽取的42(50%)例患者分到实验组,主要是应用依达拉奉结合常规治疗方法进行,而另外的42(50%)例患者则分为对照组,应用的治疗方法主要是常规治疗方法,常规治疗方法主要是利用肠溶阿司匹林、奥扎格雷钠和脉络宁进行治疗,治疗时间为半个月。结果在进行为期半个月的治疗之后,经过数据分析,实验组比对照组的治疗效率要高,并且实验组的不良反应轻微至可忽略。结论对于治疗急性脑梗死的病症中,在常规治疗的基础之上还可以结合依达拉奉进行治疗,结合依达拉奉进行治疗效果好,副作用小,值得推广应用。
Objective This article aims to observe the clinical effect of edaravone in the treatment of acute cerebral infarction. METHODS: Eighty-four patients with acute cerebral infarction who were admitted to our hospital from 2010 to 2012 were randomly divided into two groups. Forty-two patients (50%) were randomly divided into experimental group and were treated with edaravone Conventional treatment, while the other 42 (50%) patients were divided into control group, the application of the treatment method is mainly conventional treatment, the conventional treatment is mainly the use of enteric-coated aspirin, ozagrel sodium and Mailuoning treatment , The treatment time is half a month. Results After half a month of treatment, the experimental group was treated with higher efficiency than the control group through data analysis, and the adverse reactions in the experimental group were as slight as negligible. Conclusion For the treatment of acute cerebral infarction, it can be treated with edaravone on the basis of conventional treatment. The effect of edaravone combined with edaravone is good and the side effect is small, which is worth popularizing and applying.